History

A list of downloadable documents created during development.

Review proposal consultation

Psoriatic arthritis (active) - ustekinumab (Rapid Rev TA313) [ID819]: equality impact assessment form - guidance development

Psoriatic arthritis (active) - ustekinumab (Rapid Rev TA313) [ID819]: final appraisal determination

Psoriatic arthritis (active) - ustekinumab (Rapid Rev TA313): appraisal consultation